Course Highlights:
-This interactive course provides important updates in infectious diseases including a review of new developments, guidelines and literature in the field.
-Information is presented in case-based and interactive sessions, in-depth discussions, and debates, and is geared towards increasing clinician knowledge, performance and patient outcomes.
-Topics for 2019 include: emerging global infections, central nervous system infections, new molecular microbiology diagnostics, hepatitis B and C, tuberculosis and non-tuberculous mycobacterial infections, Clostridium difficile infection, gram-negative resistance and new antimicrobials for gram-negative organisms, and review of new guidelines and topics that have day-to-day relevance to the ID clinician.
-Attendees will leave with up-to-date, practical information that can be applied immediately to their clinical practice.
-Join us on the morning of Sunday, February 3rd for a session designed to target recognition and response to burnout. This activity shifts paradigm for providers from a traditional medical model to a preventive model.
Learning Objectives
Upon conclusion of this program, participants should be able to:
-Explain the diagnosis and management of emerging global infectious diseases
-Identify and describe principles of diagnosis and management of hepatitis B and C and co-infection of hepatitis C and HIV
-Document the spectrum of non-tuberculous and tuberculous mycobacterial infections
-Confidently identify advances in molecular diagnostics including significance of the microbiome
-Describe epidemiology and new treatment paradigms in gram-negative bacterial infections
Please see the course website for full credit information.
-This interactive course provides important updates in infectious diseases including a review of new developments, guidelines and literature in the field.
-Information is presented in case-based and interactive sessions, in-depth discussions, and debates, and is geared towards increasing clinician knowledge, performance and patient outcomes.
-Topics for 2019 include: emerging global infections, central nervous system infections, new molecular microbiology diagnostics, hepatitis B and C, tuberculosis and non-tuberculous mycobacterial infections, Clostridium difficile infection, gram-negative resistance and new antimicrobials for gram-negative organisms, and review of new guidelines and topics that have day-to-day relevance to the ID clinician.
-Attendees will leave with up-to-date, practical information that can be applied immediately to their clinical practice.
-Join us on the morning of Sunday, February 3rd for a session designed to target recognition and response to burnout. This activity shifts paradigm for providers from a traditional medical model to a preventive model.
Learning Objectives
Upon conclusion of this program, participants should be able to:
-Explain the diagnosis and management of emerging global infectious diseases
-Identify and describe principles of diagnosis and management of hepatitis B and C and co-infection of hepatitis C and HIV
-Document the spectrum of non-tuberculous and tuberculous mycobacterial infections
-Confidently identify advances in molecular diagnostics including significance of the microbiome
-Describe epidemiology and new treatment paradigms in gram-negative bacterial infections
Please see the course website for full credit information.
